Portfolio Finder

mediaire GmbH was founded in 2018 in Berlin by experienced MRT and AI experts in order to support radiologists with innovative software solutions for the automatic diagnosis of MRT images. mediaire's solutions can be fully integrated into the internal IT infrastructure of radiology centers to ensure a smooth workflow and the highest possible protection of sensitive patient data. The first product md.Brain, which can be used for early detection and follow-up of neurodegenerative diseases, is already certified as a medical device and is therefore available for immediate use. Among the co-founders are two medical physicists with expertise in MRI and CI (Dr. Andreas Lemke and Dr. Jörg Döpfert), as well as two experienced scientists and specialists in radiology (Prof. Dr. med. Henrik Michaely and Prof. Dr. med. Michael Fenchel).

MEINPROSPEKT aims to be a “shopping-center at your finger-tips”. It contains all your favorite brands. It´s always open, it´s great big and it´s really simple. Offline and online shopping on your personal mobile device.

Exit since July 2014. Purchaser: kaufDA

memetis develops foil-based miniature actuators made of shape memory alloys (SMA). SMA are metallic alloys that seem to "remember" a certain shape by electric heating that has been trained beforehand and then assume it independently. The alloy already disposes of these properties, so that no further mechanical components are required. memetis actuators thus enable high switching forces with better integration and higher flexibility compared to conventional solutions. memetis has the expertise to quickly adapt the developed actuators to customer requirements. Due to the extended range of applications, memetis actuators are used in a multitude of innovative industries and sectors.

MessengerPeople enables Marketing Automation, Customer Service and Chatbots via Instant Messenger like WhatsApp, Apple Business Chat and Facebook Messenger.

MetisMotion is a Munich based tech Start-up, founded in 2018. Its core competence covers ultra-dynamic and space/ weight saving linear force actuators. The MetisMotion technology platform combines decades of experience in actuator development for challenging automotive and industrial applications. It is further addressing diverse use-cases, spanning from aviation to robotics.
Compared to conventional linear actuators, MetisMotion actuators are up to 80% smaller and lighter and respond up to 10x faster. In addition, they bring inherent sensing capabilities, which would not be readily available in electromagnetic, hydraulic or pneumatic solutions. This allows MetisMotion solutions to drive the electrification of hydraulics for the Industry 4.0 revolution.

metoda provides a tool for e-commerce participants to monitor prices, analyze the market, and optimize the profit. Retailers can also identify new products and plan inventory levels based on actual demands.

Midel Photonics GmbH was founded in May 2022 and emerged from research in the "ML4Q" Cluster of Excellence at the University of Bonn. With its innovative laser beam shaping technology, the company solves highly topical problems in laser material processing and enables highly efficient laser systems. The founders were supported by EXIST research transfer funding from the BMWK, NRW.BANK, the High-Tech.NRW network, the enaCom transfer center at the University of Bonn and the RWTH Aachen incubation program. The founding team consists of David Dung, Frederik Wolf, Christian Wahl, Christopher Grossert.

MinCell develops innovative technologies and recipes for foam-glass gravel and board production. We are aiming to be the cost leader with high quality in this segment (me-too product). Having successfully finished our R&D and testing phase, we are in the process of setting up our manufacturing and distribution footprint for the European market.

Exit since August 2014.

The Leipzig startup was founded in 2017 by Robin Maier, Lukas Stenzel and David Schumann and shortly afterwards was accepted to the SpinLab Startup Accelerator. Since then, clients such as BOSCH and AOK PLUS have been acquired. At the end of last year, a cooperation agreement was also concluded with a German health insurance company. MINDANCE clients thus receive a financial subsidy of up to 100% for the use of MINDANCE. This year this model is to be rolled out on a large scale in cooperation with other health insurance companies.

minubo is an eCommerce “as a Service“ solution that makes online retailers drive their growth by converting data into action – on the basis of comprehensive possibilities of analyzing and reporting.

miRdetect is a biotechnology company founded in 2016, with the aim to revolutionise cancer diagnostics. The focus is on development, production and distribution of in-vitro diagnostics based on molecular diagnostic methods. The first product, based on the quantification of microRNA, is a blood test for the detection of testicular cancer. The high sensitivity and accuracy of the test improves the diagnosis and therapy of patients significantly and reduces the costs for the health care system. miRdetect has developed a patented platform technology, which allows the exact and reliable quantification of small amounts of genetic material in body fluids. This robust method represents the basis for the development of additional diagnostic tests.

Mister Spex is the largest online retailer for designer glasses in Germany. The company offers a wide variety of high quality glasses, sunglasses, sport glasses as well as contact lenses, that can be bought at fair prices via Internet.

MoBerries is Germany's largest shared candidate pool. The corporate network consists of leading DAX and digital companies as well as venture capital funds. All member companies recommend candidates for urgent posts. The MoBerries software filters candidate quality and can be integrated directly into companies’ applicant tracking systems.

Mobilversichert provides a SaaS platform to digitize insurance brokers and facilitate online brokerage. Using a unique combination of broker platform and B2B2C mobile app, insurance brokers get the digital tools to conduct their business in a transforming market. Automatized workflows enable brokers to manage their clients efficiently and smart. With Mobilversichert brokers can tap into new digital clientele while defending their traditional business against digital contenders.

Mosanna is a Swiss Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. We carefully select innovative medicines for further development using the best contract research organisations in the specific specialised field. Our first goal is to bring an effective and well tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients.

multiBIND develops innovative solutions for molecular biology, healthcare and agriculture. bioDECONT® and bioCLEAN represent biocompatible disinfection and decontamination in laboratories, hospitals and agriculture.

Multiphoton Optics develops 3D printers for the serial production of optical components with previously unattainable precision.

MYR

Exit

MYR develops a novel, peptide-based, first-in-class drug (entry inhibitor) for the treatment of chronic hepatitis B and Delta infections. Clinical phase IIb currently in preparation.

Nanda sells wafer inspection systems to chip manufacturer world wide. The innovative optical design allows for faster inspection speed. This reduces costs dramatically and increases yield in the production process.

Exit since Nov. 2011. Purchaser: Nanometrics Inc. (Nasdaq: NANO).

Natif.ai is a deep-tech start-up in the field of intelligent document process automation (IDP). Thanks to high-performance AI models and a self-developed Deep-OCR, a wide variety of documents can be analyzed extremely quick, accurate and relevant data is extracted. Natif.ai provides a fast and efficient way to productively bring artificial intelligence into the economy. It was founded by a German-French team and is an official spin-off of the German Research Institute for Artificial Intelligence (DFKI).

Nebula Biocides GmbH was founded in 2019 as a spin-off from the Leibniz Institute for Plasma Science and Technology (INP) by the scientists Dr. Jörn Winter, Dr. Ansgar Schmidt-Bleker and the director of INP Prof. Dr. Klaus-Dieter Weltmann. With the aim of providing comprehensive protection against infectious pathogens, the company develops application-oriented disinfection solutions that reliably kill not only bacteria and viruses but also persistent bacterial spores.

neotiv is a spin-off of the Otto von Guericke University in the German city of Magdeburg in close collaboration with the Magdeburg site of the German Centre for Neurodegenerative Diseases (DZNE). neotiv incorporates the latest scientific findings from the fields of neuroscience and dementia research into mobile software that can be used on smartphones and tablets. Our work focuses on the development of a digital assistant that can monitor and aid users' memories and provide support for patients with dementia. neotiv is also designed to improve the early detection of Alzheimer's dementia and to facilitate efficacy monitoring for new therapies as they become available in the future. Biologically and anatomically valid and user-oriented measurements of specific memory functions, which can be carried out on a regular basis, form the core of the development of neotiv. The measurements focus on regions of the brain that are affected in the early stages of Alzheimer's disease. The vision behind neotiv is to (i) help reducing risk factors for cognitive decline by making lifestyle change simple and cognitive health measurable and (ii) to enable the innovative early detection of cognitive difficulties and dementia risk.

Deep learning and AI have revolutionized how images, sounds and natural language are processed. However, software for Computer-Aided Design (CAD) for the development of technical products is still using traditional techniques. Neural Concept Shape is the first deep learning software solution dedicated to Computer Assisted Engineering and Design. The cloud-based simulation software allows clients to speed up development cycles, enhance product performance and reduce computational costs.

Neural Concept was founded in the spring of 2018. The start-up is a spin-off from EPFL’s computer vision laboratory where the founding team developed the fundamental technology. The company has also been supported by the Venture Kick support scheme.

Next Kraftwerke links microgeneration plants and creates a virtual power plant. Pooling such plants makes unused resources available to the electricity market

NFON

Exit

We connect the world in Munich. In 2007 we stirred up the blue and white sky above Bavaria with an invisible cloud. A very special cloud still revolutionizing worldwide business telephony to this day. We’re NFON AG, a worldwide leading provider of high-end telephone systems from the cloud. More than 150 creative, skilled and passionate employees in Munich, Mainz and over ten countries (eight other branches) throughout Europe ensure you stay talking. Whenever you want. Wherever you want. With whomever you want.

We take the telephone system out of the office – and into the NFON high performance computer centers. With an encrypted internet connection you can now access your phone system from around the world by phone, computer or smartphone, always connected to the classic telephone network.

Regardless of location, flexible, free and at a low price. And thanks to free for life cloud updates you’re always up to date. We make everyday business life a little simpler. And your communications more secure.

Whether you’re a local small business or international major enterprises: Our cloud telephone system can serve businesses of 2 to 249,000 employees. That’s what we like to do. That’s what we do best. With more than 10,000 satisfied customers. We’ve also received a certificate and seal from TÜV Saarland. And frequent praise from the media. ChannelPartner elected us the best known provider of cloud telephony service, the Handelsblatt writes about “calls from cloud 9”. And we keep doing what we know best: we connect what belongs together.

Nia Health is a spin-off of the Charité Universitätsmedizin Berlin. The start-up develops a clinical diagnosis and therapy system for the continuous digital support of patients with chronic skin conditions. With its platform, Nia Health addresses an often highly underserved patient population and generates treatment-relevant real world evidence. With its innovative machine vision approach, Nia Health enables accurate documentation of disease and therapy progression and thus optimised treatment. The company works closely with German patient associations and leading clinicians and has already won reputable customers from
the insurance and pharmaceutical industries. Amongst others, the Berlin-based company has developed the award-winning apps in the fields of atopic dermatitis (Nia) and psoriasis (Sorea), which were the first digital medical products of their kind to be approved worldwide. The digital medical solutions from Nia Health provide daily support for thousands of patients and their families.

node.energy offers a software-as-a-service for the commercial optimization of local energy concepts – so-called microgrids. This allows industrial and commercial companies with on-site power generation to reduce both, their energy costs and CO2 footprint. The company is supported by the Climate-KIC Accelerator of the European Union and is the winner of the Startup Award 2017 of the auditing company EY. node.energy was founded in 2016 by Matthias Karger and Lars Rinn and is based in Frankfurt am Main.

Nordantech develops an intelligent project management software for enterprise transformations: Falcon. Falcon makes it possible to coordinate and manage complex projects in addition to the daily business in terms of milestones and financial effects through time-saving and clear-cut features. Falcon learns independently. Hence delays are detected early. Since Falcon can be used simultaneously in any number of departments and companies, especially management consultancies, holding companies and private equity firms enjoy Falcon.

In order to successfully treat the infected patient, you have to recognize and diagnose most reliably the infecting microbe.
Noscendo changes the way infection causative microbes are identified. Through a paradigm shift we introduce by using proprietary algorithms and software harnessing next generation sequencing, we identify pathogens from cell free nucleic acids in patient samples and thereby aid intensive care clinicians in their daily task to find the right decisions, enabling a targeted and successful treatment in an actionable timeframe.